Compass Therapeutics (CMPX) Retained Earnings (2023 - 2025)
Historic Retained Earnings for Compass Therapeutics (CMPX) over the last 3 years, with Q3 2025 value amounting to -$415.5 million.
- Compass Therapeutics' Retained Earnings fell 1881.99% to -$415.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$415.5 million, marking a year-over-year decrease of 1881.99%. This contributed to the annual value of -$364.7 million for FY2024, which is 1565.93% down from last year.
- Compass Therapeutics' Retained Earnings amounted to -$415.5 million in Q3 2025, which was down 1881.99% from -$401.2 million recorded in Q2 2025.
- Compass Therapeutics' 5-year Retained Earnings high stood at -$280.7 million for Q1 2023, and its period low was -$415.5 million during Q3 2025.
- In the last 3 years, Compass Therapeutics' Retained Earnings had a median value of -$339.2 million in 2024 and averaged -$342.5 million.
- Per our database at Business Quant, Compass Therapeutics' Retained Earnings tumbled by 1565.93% in 2024 and then plummeted by 1881.99% in 2025.
- Quarter analysis of 3 years shows Compass Therapeutics' Retained Earnings stood at -$315.3 million in 2023, then fell by 15.66% to -$364.7 million in 2024, then fell by 13.92% to -$415.5 million in 2025.
- Its Retained Earnings was -$415.5 million in Q3 2025, compared to -$401.2 million in Q2 2025 and -$381.3 million in Q1 2025.